Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
The brain cells of people affected by Parkinson’s disease are stuffed with toxic proteins. Aggregates called Lewy bodies are ...
HealthDay News — Subthalamic deep brain stimulation (DBS) is an effective long-term therapy for Parkinson disease (PD), according to a study published online September 15 in JAMA Neurology.
Readers, many with Parkinson’s, respond to an article about Sue Goldie, who has the disease. Also: Tears over Trump’s America ...
Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...
The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...
Researchers led by a team from the University of Bath in the UK have achieved just that in a basic worm model of Parkinson's.
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has begun across the UK.
Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's ...
The latest update is out from PharmaTher Holdings Ltd ( (TSE:PHRM) ).
Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...
Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoing Toronto, Ontario–(Newsfile Corp.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback